Ethylenediaminetetraacetic Acid ophthalmic solution
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ethylenediaminetetraacetic Acid ophthalmic solution, covering 2024-04-16 to 2024-04-16. Get the full timeline:
Most recent: Clinical Trial Update: The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract [Phase 1, Phase 2]